IL128573A0 - Treatment of upper airway allergic responses with a combination of histamine receptor antagonists - Google Patents

Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Info

Publication number
IL128573A0
IL128573A0 IL12857397A IL12857397A IL128573A0 IL 128573 A0 IL128573 A0 IL 128573A0 IL 12857397 A IL12857397 A IL 12857397A IL 12857397 A IL12857397 A IL 12857397A IL 128573 A0 IL128573 A0 IL 128573A0
Authority
IL
Israel
Prior art keywords
treatment
combination
receptor antagonists
upper airway
histamine receptor
Prior art date
Application number
IL12857397A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL128573A0 publication Critical patent/IL128573A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL12857397A 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists IL128573A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68995196A 1996-08-16 1996-08-16
PCT/US1997/013903 WO1998006394A1 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Publications (1)

Publication Number Publication Date
IL128573A0 true IL128573A0 (en) 2000-01-31

Family

ID=24770500

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12857397A IL128573A0 (en) 1996-08-16 1997-08-13 Treatment of upper airway allergic responses with a combination of histamine receptor antagonists

Country Status (25)

Country Link
EP (1) EP0920315B1 (xx)
JP (2) JP3638289B2 (xx)
KR (1) KR20000029975A (xx)
CN (1) CN1152682C (xx)
AR (1) AR008293A1 (xx)
AT (1) ATE314071T1 (xx)
AU (1) AU722040B2 (xx)
BR (1) BR9711149A (xx)
CA (1) CA2263163A1 (xx)
CO (1) CO4910138A1 (xx)
CZ (1) CZ43299A3 (xx)
DE (1) DE69734984D1 (xx)
HU (1) HUP9904362A3 (xx)
ID (1) ID17871A (xx)
IL (1) IL128573A0 (xx)
MY (1) MY116130A (xx)
NO (1) NO990706L (xx)
NZ (1) NZ334063A (xx)
PE (1) PE100298A1 (xx)
PL (1) PL191073B1 (xx)
SK (1) SK20099A3 (xx)
TR (1) TR199900326T2 (xx)
TW (2) TW200427450A (xx)
WO (1) WO1998006394A1 (xx)
ZA (1) ZA977263B (xx)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042379A2 (en) * 1997-03-26 1998-10-01 Sepracor Inc. Chemically and thermally stable norastemizole formulations
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
US5990147A (en) * 1997-11-07 1999-11-23 Schering Corporation H3 receptor ligands of the phenyl-alkyl-imidazoles type
US6034251A (en) * 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
ES2188029T3 (es) * 1997-11-07 2003-06-16 Schering Corp Fenil-alquil-imidazoles como antagonistas del receptor h3.
TW421645B (en) * 1997-11-07 2001-02-11 Schering Corp H3 receptor ligands of the phenyl-alkyl-imidazoles type
IL135727A0 (en) * 1997-11-07 2001-05-20 Schering Corp Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
JP2002527381A (ja) * 1998-10-09 2002-08-27 シェーリング コーポレイション アレルギー性疾患を処置するための組成物および方法
US6100279A (en) * 1998-11-05 2000-08-08 Schering Corporation Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
WO2001021162A2 (en) * 1999-09-22 2001-03-29 Schering Corporation Treating allergic and inflammatory conditions using desloratadine
AU3800601A (en) 2000-02-03 2001-08-14 Schering Corporation Treating allergic and inflammatory conditions
PE20020507A1 (es) 2000-10-17 2002-06-25 Schering Corp Compuestos no-imidazoles como antagonistas del receptor histamina h3
GB2373186A (en) * 2001-02-23 2002-09-18 Astrazeneca Ab Pharmaceutical combinations of a CCR3 antagonist and a compound which is usefulreatment of asthma, allergic disease or inflammation
AU2002244271A1 (en) 2001-03-13 2002-09-24 Pharmacopeia, Inc. Non-imidazole compounds as histamine h3 antagonists
US7105505B2 (en) 2002-04-18 2006-09-12 Schering Corporation Benzimidazole derivatives useful as histamine H3 antagonists
PE20040464A1 (es) 2002-04-18 2004-07-24 Schering Corp Benzimidazolonas sustituidas y derivados como antagonistas de histamina h3
MY135686A (en) 2002-06-24 2008-06-30 Schering Corp Indole derivatives useful as histamine h3 antagonists
US20050090527A1 (en) * 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
WO2007001975A1 (en) 2005-06-20 2007-01-04 Schering Corporation Piperidine derivatives useful as histamine h3 antagonists
US20110166124A1 (en) 2008-07-23 2011-07-07 Mccormick Kevin D Tricyclic spirocycle derivatives and methods of use
WO2010045306A2 (en) 2008-10-16 2010-04-22 Schering Corporation Azine derivatives and methods of use thereof
US8283360B2 (en) 2008-12-19 2012-10-09 Merck Sharp & Dohme Corp. Bicyclic heterocyclic derivatives and methods of use thereof
EP2379565A1 (en) 2008-12-19 2011-10-26 Schering Corporation Piperidine and piperazine derivatives and methods of use thereof
US8569273B2 (en) 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
PT2408453T (pt) 2009-03-17 2022-04-05 Nicox Ophthalmics Inc Formulações oftálmicas de cetirizina e métodos de utilização
EP2429530B1 (en) * 2009-05-14 2018-11-07 The General Hospital Corporation (s)-meclizine for treating ischaemia-reperfusion injury
EP2485735B1 (en) 2009-10-08 2015-07-29 Merck Sharp & Dohme Corp. Inhibitors of fatty acid binding protein (fabp)
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
RU2685277C1 (ru) * 2018-05-24 2019-04-17 Общество с ограниченной ответственностью "Фарминтерпрайсез Аллерджи" Применение бисамидного производного малоновой кислоты для лечения аллергических и других заболеваний человека и животных

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201683B (en) * 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US5019591A (en) * 1989-02-17 1991-05-28 Pennsylvania Research Corporation Method for treating retinopathy and other small vessel disorders associated with diabetes
GB9303210D0 (en) * 1993-02-17 1993-03-31 Univ Manitoba Cancer treatment

Also Published As

Publication number Publication date
JP2003095979A (ja) 2003-04-03
NO990706D0 (no) 1999-02-15
EP0920315B1 (en) 2005-12-28
AR008293A1 (es) 1999-12-29
PL331617A1 (en) 1999-08-02
CN1233179A (zh) 1999-10-27
CA2263163A1 (en) 1998-02-19
BR9711149A (pt) 1999-08-17
JP2000505094A (ja) 2000-04-25
WO1998006394A1 (en) 1998-02-19
DE69734984D1 (de) 2006-02-02
NO990706L (no) 1999-02-15
TW200427450A (en) 2004-12-16
PE100298A1 (es) 1999-01-11
TR199900326T2 (xx) 1999-05-21
AU3973397A (en) 1998-03-06
HUP9904362A2 (hu) 2000-11-28
AU722040B2 (en) 2000-07-20
CZ43299A3 (cs) 1999-07-14
KR20000029975A (ko) 2000-05-25
PL191073B1 (pl) 2006-03-31
JP3638289B2 (ja) 2005-04-13
CN1152682C (zh) 2004-06-09
ATE314071T1 (de) 2006-01-15
CO4910138A1 (es) 2000-04-24
NZ334063A (en) 2000-09-29
HUP9904362A3 (en) 2000-12-28
TWI221768B (en) 2004-10-11
EP0920315A1 (en) 1999-06-09
MY116130A (en) 2003-11-28
ID17871A (id) 1998-02-05
ZA977263B (en) 1998-02-16
SK20099A3 (en) 2000-08-14

Similar Documents

Publication Publication Date Title
IL128573A0 (en) Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
ZA964744B (en) Crf receptor antagonists and methods relating thereto
HU9603525D0 (en) Vironectin receptor antagonists
HK1003884A1 (en) Quinoline derivatives as tachykinin nk3 receptor and antagonists
IL116203A0 (en) NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
IL115613A0 (en) Bicyclic neuropeptide y receptor antagonists
PL311272A1 (en) Antagonists of endotheline receptors
PL331539A1 (en) Antagonists of il-8 receptor
IL111379A0 (en) Histamine h3-receptor antagonists and therapeutic uses thereof
GB9905275D0 (en) Treatment of conditions associated with membrane-bound receptors and their function
PL328633A1 (en) Oxazolic and thiadizolic antagonists of muscarinic receptors
PL310386A1 (en) Antagonists of factor i receptors
IL113050A0 (en) Antagonists of endothelin receptors
HK1021372A1 (en) Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
ZA9510686B (en) Human somatostatin-like receptor
EP0711830A3 (en) Murine and human galanin receptor
ZA959434B (en) Adhesion receptor antagonists
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
EP0747055A3 (en) Use of tachykinin receptor antagonists to treat the common cold and allergic rhinitis
PL320638A1 (en) Antagonists of endothein receptors
IL118299A0 (en) Pharmacological use of AII-receptor antagonists
HU9602127D0 (en) Endotheline receptor antagonists
AU3116697A (en) Human interleukin-1j and antagonists thereof
AU3935897A (en) B1-bradykinin receptor antagonists and use thereof
EP0792282A4 (en) BOMBESIN AND ENDOTHELIN RECEPTOR OF HUMAN ORIGIN